
FYR Diagnostics: Pioneering biomarker detection tech for human health and agriculture since 2016.
Founded in 2016 and headquartered in Missoula, Montana, FYR Diagnostics is dedicated to pioneering biomarker detection technology aimed at combating chronic diseases in both human healthcare and agriculture. The company’s core mission is to transform healthcare by developing innovative solutions that leverage novel insights into disease, particularly through next-generation liquid biopsies. FYR Diagnostics focuses on bridging the gaps between healthcare providers, patients, and disease management.
Key figures affiliated with FYR Diagnostics include a team of experts in biotechnology and healthcare innovation. The company has achieved significant milestones in advancing diagnostic technologies and has garnered attention for its potential impact on early disease detection and management. By pushing the boundaries of biomarker detection, FYR Diagnostics has made a notable impact on improving diagnostic accuracy and patient outcomes, thereby contributing to the broader goal of enhancing global health standards.

Foresight Diagnostics
foresight-dx.com

Smart Diagnostics Systems

Empowered Diagnostics

Accelevir Diagnostics

Chosen Diagnostics

Persperion Diagnostics
persperiontech.com

Instadiagnostics

Nanopath
nanopathdx.com

Gregor Diagnostics

Pharus Diagnostics
pharusdx.com

Gamma Diagnostics

Acuamark Diagnostics
acuamarkdx.com

Celerus Diagnostics

Micronoma
micronoma.com

Phdx
Companies similar to FYR Diagnostics include Foresight Diagnostics, Smart Diagnostics Systems, Empowered Diagnostics and Accelevir Diagnostics.
FYR Diagnostics was founded in 2016.
FYR Diagnostics' headquarters is located in Missoula, MT, US.
FYR Diagnostics' most recent funding round was for $256k (USD) in November 2020.
As of Nov 23, 2020, FYR Diagnostics has raised a total of $3M (USD).
FYR Diagnostics has 16 employees as of Feb 4, 2024.